These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35180646)

  • 1. Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises.
    Eugster PJ; Bourdillon N; Vocat C; Wuerzner G; Nguyen T; Millet GP; Grouzmann E
    Neuropeptides; 2022 Apr; 92():102232. PubMed ID: 35180646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saxagliptin: A potential doping agent? A randomized, double-blinded, placebo-controlled, and crossover pilot study in young active men.
    Bourdillon N; Eugster PJ; Vocat C; Nguyen T; Wuerzner G; Grouzmann E; Millet GP
    Physiol Rep; 2022 Dec; 10(23):e15515. PubMed ID: 36461653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.
    Eugster PJ; Maurer J; Vocat C; Abid K; Matter M; Wuerzner G; Trepp R; Fischli S; Henzen C; Kolb W; Bilz S; Sigrist S; Beuschlein F; Nölting S; Reul A; Schütze I; Hubers SA; Brown NJ; Grouzmann E
    Clin Chim Acta; 2022 Sep; 534():146-155. PubMed ID: 35905838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
    Zhu X; Gillespie DG; Jackson EK
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography-Tandem Mass Spectrometry.
    Reverter-Branchat G; Eugster PJ; Kuenzli C; Rindlisbacher B; Stauffer T; Nakas CT; Herzig D; Grouzmann E; Bally L
    Clin Chem; 2022 Mar; 68(4):584-594. PubMed ID: 35015868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
    Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
    J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuropeptide Y (NPY) in the control of LH secretion in the ewe with respect to season, NPY receptor subtype and the site of action in the hypothalamus.
    Barker-Gibb ML; Scott CJ; Boublik JH; Clarke IJ
    J Endocrinol; 1995 Dec; 147(3):565-79. PubMed ID: 8543927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clonidine on plasma catecholamines and neuropeptide Y in hypertensive patients at rest and during stress.
    Puybasset L; Lacolley P; Laurent S; Mignon F; Billaud E; Cuche JL; Comoy E; Safar M
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):912-9. PubMed ID: 7687716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Neuropeptide Y and Four of Its Metabolites in Human Plasma by Micro-UHPLC-MS/MS.
    Vocat C; Dunand M; Hubers SA; Bourdillon N; Millet GP; Brown NJ; Wuerzner G; Grouzmann E; Eugster PJ
    Anal Chem; 2020 Jan; 92(1):859-866. PubMed ID: 31790196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.
    Sigala B; McKee C; Soeda J; Pazienza V; Morgan M; Lin CI; Selden C; Vander Borght S; Mazzoccoli G; Roskams T; Vinciguerra M; Oben JA
    PLoS One; 2013; 8(9):e72928. PubMed ID: 24019886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
    Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
    Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise-induced changes in plasma catecholamines and neuropeptide Y: relation to age and sampling times.
    Jensen EW; Espersen K; Kanstrup IL; Christensen NJ
    J Appl Physiol (1985); 1994 Mar; 76(3):1269-73. PubMed ID: 8005872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved ventilation and decreased sympathetic stress in chronic heart failure patients following local endurance training with leg muscles.
    Gordon A; Tyni-Lenné R; Jansson E; Kaijser L; Theodorsson-Norheim E; Sylvén C
    J Card Fail; 1997 Mar; 3(1):3-12. PubMed ID: 9110249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of sympathetic neuron neuropeptide Y and catecholamine content and secretion.
    May V; Brandenburg CA; Braas KM
    J Neurosci; 1995 Jun; 15(6):4580-91. PubMed ID: 7790925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y (NPY) inhibits spontaneous contraction of the mouse atrium by possible activation of the NPY1 receptor.
    Oki Y; Teraoka H; Kitazawa T
    Auton Autacoid Pharmacol; 2017 Mar; 37(2):23-28. PubMed ID: 28544313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats.
    Zukowska-Grojec Z; Konarska M; McCarty R
    Life Sci; 1988; 42(17):1615-24. PubMed ID: 3367684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
    Christensen M; Ibsen H; Worck R
    Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of sympathetic activity by brain neuropeptide Y in cardiac hypertrophy.
    Woo ND; Sahai A; Anderson WA; Ganguly PK
    Am Heart J; 1991 Oct; 122(4 Pt 1):1028-34. PubMed ID: 1833961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats.
    Marchand JE; Cepeda MS; Carr DB; Wurm WH; Kream RM
    Pain; 1999 Feb; 79(2-3):187-200. PubMed ID: 10068164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.